Name (Synonyms) | Correlation | |
---|---|---|
drug1231 | Intermediate dose thromboprophylaxis Wiki | 1.00 |
drug2325 | Standard of Care thromboprophylaxis Wiki | 1.00 |
drug1822 | Placebo Wiki | 0.06 |
There is one clinical trial.
The purpose of this clinical trial is to assess the safety and efficacy of Clevudine 120 mg versus placebo once daily administration with standard of care therapy for 14 days (maximum up to 21 days) in patients with moderate COVID-19.
Description: The primary efficacy endpoint for this clinical trial is the rate of patients with negative SARS-Coronavirus-2 (SARS-CoV-2) in a two-day continuous Real-Time-RT-PCR test from baseline to before the 15th day.
Measure: The rate of subjects tested as negative SARS-Coronavirus-2 (SARS-CoV-2) Time: within 15days